Glibenclamide Is Comparable to Target Temperature Management in Improving Survival and Neurological Outcome After Asphyxial Cardiac Arrest in Rats

BACKGROUND: We previously have shown that glibenclamide (GBC), a sulfonylurea receptor 1–transient receptor potential M4 (SUR1‐TRPM4) channel inhibitor, improves survival and neurological outcome after asphyxial cardiac arrest and cardiopulmonary resuscitation (ACA/CPR). Here, we further compare the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Huang, Kaibin, Wang, Ziyue, Gu, Yong, Hu, Yafang, Ji, Zhong, Wang, Shengnan, Lin, Zhenzhou, Li, Xing, Xie, Zuoshan, Pan, Suyue
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015382/
https://ncbi.nlm.nih.gov/pubmed/27413041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003465
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados